1. Home
  2. BMEA vs BOOM Comparison

BMEA vs BOOM Comparison

Compare BMEA & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • BOOM
  • Stock Information
  • Founded
  • BMEA 2017
  • BOOM 1965
  • Country
  • BMEA United States
  • BOOM United States
  • Employees
  • BMEA N/A
  • BOOM N/A
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • BOOM Industrial Specialties
  • Sector
  • BMEA Health Care
  • BOOM Industrials
  • Exchange
  • BMEA Nasdaq
  • BOOM Nasdaq
  • Market Cap
  • BMEA 275.6M
  • BOOM 223.6M
  • IPO Year
  • BMEA 2021
  • BOOM N/A
  • Fundamental
  • Price
  • BMEA $11.24
  • BOOM $12.93
  • Analyst Decision
  • BMEA Buy
  • BOOM Strong Buy
  • Analyst Count
  • BMEA 13
  • BOOM 2
  • Target Price
  • BMEA $36.33
  • BOOM $20.00
  • AVG Volume (30 Days)
  • BMEA 1.1M
  • BOOM 146.8K
  • Earning Date
  • BMEA 11-01-2024
  • BOOM 10-31-2024
  • Dividend Yield
  • BMEA N/A
  • BOOM N/A
  • EPS Growth
  • BMEA N/A
  • BOOM N/A
  • EPS
  • BMEA N/A
  • BOOM 0.64
  • Revenue
  • BMEA N/A
  • BOOM $684,231,000.00
  • Revenue This Year
  • BMEA N/A
  • BOOM N/A
  • Revenue Next Year
  • BMEA N/A
  • BOOM $4.73
  • P/E Ratio
  • BMEA N/A
  • BOOM $20.20
  • Revenue Growth
  • BMEA N/A
  • BOOM N/A
  • 52 Week Low
  • BMEA $3.61
  • BOOM $10.45
  • 52 Week High
  • BMEA $22.74
  • BOOM $19.73
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 64.18
  • BOOM 51.30
  • Support Level
  • BMEA $10.35
  • BOOM $12.66
  • Resistance Level
  • BMEA $12.30
  • BOOM $13.31
  • Average True Range (ATR)
  • BMEA 0.93
  • BOOM 0.47
  • MACD
  • BMEA -0.01
  • BOOM -0.06
  • Stochastic Oscillator
  • BMEA 47.26
  • BOOM 26.32

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About BOOM DMC Global Inc.

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

Share on Social Networks: